Get the StoQuant digest — free

Free StoQuant digest by email. No account needed. See today's research picks.

Subscribe free

GSBD vs HIVE — Stock Comparison

Compare GSBD and HIVE side-by-side on StoQuant: GSBD Q-Score 42 vs HIVE 43; analyst signal 44 vs 74. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.

Side-by-side snapshot

• GSBD — Goldman Sachs BDC, Inc. · Financials · market cap $970M · Q-Score verdict Hold (42.0, grade C) · analyst signal 44/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: valuation 74/100, technicals 34/100 · weakest signals: competitive moat 30/100, analyst consensus 7/100. Full GSBD research.
• HIVE — HIVE Digital Technologies Ltd. · Financials · market cap $529M · Q-Score verdict Hold (43.0, grade C) · analyst signal 74/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: valuation 79/100, analyst consensus 68/100 · weakest signals: competitive moat 30/100, technicals 24/100. Full HIVE research.

What you can compare

• Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
• Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
• Insider activity: Cluster scores and recent Form 4 buying.
• Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
• Strategic edges: Competitive moat and durable advantage analysis.
• Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
• Macro context: Market regime and sector rotation alignment.

Deep dive: GSBD research · HIVE research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →